| Studies | Unique Samples per Visibility Status | Public Samples per Data Type | Users | Jobs |
|---|---|---|---|---|
|
public: 889 private: 176 sandbox: 2,988 submitted to EBI: 1,148 |
public: 438,380 private: 118,389 sandbox: 662,147 submitted to EBI: 390,512 submitted to EBI (prep): 454,883 |
16S: 389,577 18S: 12,149 ITS: 15,550 Metagenomic: 105,516 Full Length Operon: 803 Metatranscriptomic: 27,161 Metabolomic: 1,545 Genome Isolate: 1,505 |
17,428 | 937,552 |
PBisphenol A (BPA) accumulates in the maturing gut and liver in utero and is known to alter gut bacterial profiles in offspring. Gut bacterial dysbiosis may contribute to chronic colonic and systemic inflammation. We hypothesized that perinatal BPA exposure-induced intestinal (and liver) inflammation in offspring is due to alterations in the microbiome and colonic metabolome. The 16S rRNA amplicon sequencing analysis revealed differences in beta diversity with a significant reduction in the relative abundances of short-chain fatty acid (SCFA) producers such as Oscillospira and Ruminococcaceae due to BPA exposure. Furthermore, BPA exposure reduced fecal SCFA levels and increased systemic lipopolysaccharide (LPS) levels. BPA exposure-increased intestinal permeability was ameliorated by the addition of SCFA in vitro. Metabolic fingerprints revealed alterations in global metabolism and amino acid metabolism. Thus, our findings indicate that perinatal BPA exposure may cause gut bacterial dysbiosis and altered metabolite profiles, particularly SCFA profiles, leading to chronic colon and liver inflammation.